IFM Investors Pty Ltd Takes Position in Bath & Body Works, Inc. $BBWI

Key Points

• IFM Investors Pty Ltd has acquired 41,177 shares of Bath & Body Works, Inc. for approximately $1.314 million, marking a significant investment in the company.
• Bath & Body Works reported quarterly earnings of $0.37 per share, meeting analysts' expectations, but the company's revenue decreased by 0.8% year-over-year.
• The company announced a quarterly dividend of $0.20 per share, translating to an annual dividend of $0.80 and a yield of 2.9%.

IFM Investors Pty Ltd bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 41,177 shares of the company's stock, valued at approximately $1,314,000.

Several other institutional investors have also recently bought and sold shares of BBWI. SVB Wealth LLC bought a new stake in Bath & Body Works in the 1st quarter valued at approximately $35,000. Golden State Wealth Management LLC lifted its stake in Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after acquiring an additional 642 shares in the last quarter. UMB Bank n.a. lifted its stake in Bath & Body Works by 65.9% in the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after acquiring an additional 596 shares in the last quarter. GKV Capital Management Co. Inc. bought a new stake in Bath & Body Works in the 1st quarter valued at approximately $69,000. Finally, Brooklyn Investment Group lifted its stake in Bath & Body Works by 394.9% in the 1st quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock valued at $82,000 after acquiring an additional 2,152 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Down 2.7%

Shares of BBWI stock traded down $0.74 during trading on Monday, reaching $26.47. 7,496,200 shares of the company's stock were exchanged, compared to its average volume of 6,734,402. The stock has a market capitalization of $5.46 billion, a PE ratio of 7.85, a PEG ratio of 0.93 and a beta of 1.49. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87. The firm's fifty day moving average price is $30.18 and its 200-day moving average price is $29.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period in the prior year, the firm posted $0.37 EPS. The company's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio is currently 23.74%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on BBWI shares. JPMorgan Chase & Co. upped their price objective on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. Barclays upped their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research note on Friday, August 29th. Citigroup dropped their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. The Goldman Sachs Group dropped their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research note on Friday, May 30th. Finally, Morgan Stanley dropped their price objective on Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating on the stock in a research note on Friday. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Bath & Body Works currently has a consensus rating of "Moderate Buy" and a consensus price target of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.